Skip to main content
logo
Novartis AG (NVS)
NYSE: NVS · Real-Time Price · USD
150.62
+0.24 (0.16%)
At close: Oct 16, 2026, 4:00 PM EDT
148.56
-2.06 (-1.37%)
After-hours: Oct 16, 2026, 7:57 PM EDT

Novartis AG Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Operating Revenue
14,40813,11313,33613,90914,05413,23313,15312,82312,51211,82911,42311,78211,43710,79810,57610,492-12,53113,22913,030
Other Revenue
543411524449782387405349360291353310308249390291-283293337
Revenue
14,95113,52413,86014,35814,83613,62013,55813,17212,87212,12011,77612,09211,74511,04710,96610,783-12,81413,52213,367
Revenue Growth (YoY)
0.78%-0.70%2.23%9.00%15.26%12.38%15.13%8.93%9.60%9.71%7.39%12.14%--13.79%-18.90%-19.33%-0.95%3.78%6.61%
Cost of Revenue
3,6783,4383,5423,5353,3223,2273,3123,2343,1733,0962,5703,1173,3422,9912,7562,874-3,8563,5443,938
Gross Profit
11,27310,08610,31810,82311,51410,39310,2469,9389,6999,0249,2068,9758,4038,0568,2107,909-8,9589,9789,429
Selling, General & Admin
3,2313,1373,4363,3043,4423,0583,4993,1343,0912,8403,4163,0913,0912,8913,1332,936-3,5123,9143,618
Research & Development
2,7392,7852,8372,8642,7272,3662,3312,3922,3672,4212073,9252,3042,5751,4692,542-2,3202,0192,380
Other Operating Expenses
1274219070334265-890778256374-47829395507-1,261506-235-364256
Operating Expenses
6,0975,9646,4636,2386,5035,6894,9406,3045,7145,6353,1457,3095,4905,9733,3415,984-6,0675,5696,254
Operating Income
5,1764,1223,8554,5855,0114,7045,3063,6343,9853,3896,0611,6662,9132,0834,8691,925-2,8914,4093,175
Interest Expense
-462-343-304-281-289-270-275-264-246-221-217-222-216-200-207-206--201-206-202
Interest & Investment Income
--373---568---627---377---71-
Earnings From Equity Investments
-2-3-2-4-3-3-3-4-2-29-6-3-2-2-3-5--214,621223
Currency Exchange Gain (Loss)
---300----258----214----184----69-
Other Non Operating Income (Expenses)
194-130-7-4117-4626756-2011585104-104-6-2011-24
EBT Excluding Unusual Items
4,7313,7803,4924,2934,6784,4485,2923,3923,8123,1456,0501,4562,7801,9854,7481,708-2,70818,8373,172
Merger & Restructuring Charges
-37--478----364----951--81--1,822-----
Gain (Loss) on Sale of Investments
-61915713-41-45-722-28-366-23-4628-90--102-129
Gain (Loss) on Sale of Assets
-125--50-45-712390-12627-9-186649
Asset Writedown
-199-34-364-94-1--1,428----3,088----1,664----653-
Legal Settlements
-46-2811-163--89---89--2455-313--45-212-
Other Unusual Items
-174-51272-75-36--126---310---565-22---1,075-
Pretax Income
4,2693,8393,2184,1964,5314,4073,2853,3853,8413,1292,3771,5522,6742,5201,5691,587-2,66916,9513,230
Income Tax Expense
1,012683814266507798465200595441-26139403370254257-450645472
Earnings From Continuing Operations
3,2573,1562,4043,9304,0243,6092,8203,1853,2462,6882,6381,5132,2712,1501,3151,330-2,21916,3062,758
Earnings From Discontinued Operations
----------5,84225046144151245----
Net Income to Company
3,2573,1562,4043,9304,0243,6092,8203,1853,2462,6888,4801,7632,3172,2941,4661,575-2,21916,3062,758
Minority Interest in Earnings
7-5-217-3-24----2-1-1--2-32-
Net Income
3,2643,1562,4093,9284,0413,6062,8183,1893,2462,6888,4801,7612,3162,2931,4661,573-2,22216,3082,758
Net Income to Common
3,2643,1562,4093,9284,0413,6062,8183,1893,2462,6888,4801,7612,3162,2931,4661,573-2,22216,3082,758
Net Income Growth (YoY)
-19.23%-12.48%-14.51%23.17%24.49%34.15%-66.77%81.09%40.16%17.23%478.44%11.95%-3.19%-91.01%-42.97%-7.92%678.80%42.53%
Shares Outstanding (Basic)
1,9051,9091,9131,9261,9481,9681,9872,0122,0332,0442,0502,0622,0832,1102,1372,167-2,2252,2372,237
Shares Outstanding (Diluted)
1,9141,9161,9291,9401,9601,9792,0042,0272,0462,0562,0652,0752,0952,1202,1582,180-2,2372,2532,254
Shares Change (YoY)
-2.35%-3.18%-3.74%-4.29%-4.20%-3.74%-2.95%-2.31%-2.34%-3.02%-4.31%-4.82%--5.23%-4.22%-3.28%--1.24%-1.27%-2.08%
EPS (Basic)
1.711.651.262.042.071.831.421.581.601.324.140.851.111.090.690.73-1.007.291.23
EPS (Diluted)
1.711.651.252.022.061.821.411.571.591.314.110.851.111.080.690.72-0.997.241.22
EPS Growth (YoY)
-16.99%-9.34%-11.57%28.66%29.56%38.93%-65.63%84.60%43.00%21.53%498.67%17.73%-8.88%-90.53%-40.79%-8.79%686.13%45.24%

Additional Metrics

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Free Cash Flow
5,5613,3301,6556,2176,3333,3913,6355,9654,6152,0382,1415,1173,3512,7893,8054,500-1,3923,4244,574
Free Cash Flow Per Share
2.901.740.863.213.231.711.812.942.260.991.042.471.601.321.762.06-0.621.522.03
Dividend Per Share
--4.666---3.862---3.919---3.461---3.401-
Dividend Growth (YoY)
--20.81%----1.44%---13.24%---1.77%---0.29%-
Gross Margin
75.40%74.58%74.44%75.38%77.61%76.31%75.57%75.45%75.35%74.45%78.18%74.22%71.55%72.92%74.87%73.35%-69.91%73.79%70.54%
Operating Margin
34.62%30.48%27.81%31.93%33.78%34.54%39.14%27.59%30.96%27.96%51.47%13.78%24.80%18.86%44.40%17.85%-22.56%32.61%23.75%
Profit Margin
21.83%23.34%17.38%27.36%27.24%26.48%20.79%24.21%25.22%22.18%72.01%14.56%19.72%20.76%13.37%14.59%-17.34%120.60%20.63%
Free Cash Flow Margin
37.20%24.62%11.94%43.30%42.69%24.90%26.81%45.28%35.85%16.81%18.18%42.32%28.53%25.25%34.70%41.73%-10.86%25.32%34.22%
EBITDA
6,2995,2384,9565,7756,1035,7896,4064,7285,0404,4827,1452,9184,1073,3976,0783,125-4,1615,7904,427
EBITDA Margin
42.13%38.73%35.76%40.22%41.14%42.50%47.25%35.89%39.16%36.98%60.67%24.13%34.97%30.75%55.43%28.98%-32.47%42.82%33.12%
D&A For EBITDA
1,1231,1161,1011,1901,0921,0851,1001,0941,0551,0931,0841,2521,1941,3141,2091,2001,0481,2701,3811,252
EBIT
5,1764,1223,8554,5855,0114,7045,3063,6343,9853,3896,0611,6662,9132,0834,8691,925-2,8914,4093,175
EBIT Margin
34.62%30.48%27.81%31.93%33.78%34.54%39.14%27.59%30.96%27.96%51.47%13.78%24.80%18.86%44.40%17.85%-22.56%32.61%23.75%
Effective Tax Rate
23.71%17.79%25.30%6.34%11.19%18.11%14.16%5.91%15.49%14.09%-2.51%15.07%14.68%16.19%16.19%-16.86%3.81%14.61%
SEC Filings: 10-K · 10-Q